6:24 PM
 | 
Sep 02, 2009
 |  BC Extra  |  Company News

PTC, Roche in CNS deal

PTC Therapeutics Inc. (South Plainfield, N.J.) partnered with Roche (SIX:ROG; OTCQX:RHHBY) to develop oral small molecules against four CNS disease targets using PTC's Gene Expression Modulation by Small-molecules (GEMS) technology....

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >